Comparison of Direct Body Composition Assessment Methods in Patients With Chronic Heart Failure
Abstract
Background
We examined the validity of leg-to-leg bioelectrical impedance analysis (BIA) and near-infrared interactance (NIR) to assess body composition in chronic heart failure (CHF) patients.
Methods and Results
A total of 140 patients with CHF were enrolled in this cross-sectional study between June 2008 and July 2009. Dual energy x-ray absorptiometry (DEXA) served as the reference standard. A priori, desired precision levels were set at ±3.5% body fat and ±3.5 kg lean body mass. Mean age was 63, 74% were male, and 90% were Caucasian. BIA- and NIR-ascertained percent body fat and lean body mass were highly correlated to DEXA. Mean differences and limits of agreement for NIR were -0.3% ± 5.1% for percent body fat and 2.9 kg ± 4.3 kg for lean body mass. Mean difference and limits of agreement for BIA percent body fat was 0.8% ± 5.8%. BIA lean body mass showed poor agreement with DEXA because of variable limits of agreement across the range of measurement (Pitman’s test P < .0001).
Conclusions
In patients with CHF, both NIR and BIA accurately measure body fat. However, both methods were imprecise. NIR overestimated lean body mass and BIA was not useful to assess this parameter. Further study is required, including examination of the utility of these field methods in serially assessing body composition.
Key Words: Bioelectrical impedance analysis, near-infrared interactance, obesity, lean body mass
To access this article, please choose from the options below
Funded by the University of Alberta Hospital Foundation. A.O. is supported by a Doctoral Research Award from the Heart and Stroke Foundation of Canada. J.A.J. holds a Canada Research Chair, and J.A.E. and C.N. hold New Investigator awards, all from the Canadian Institutes of Health Research. J.A.E., F.A.M., C.N., and J.A.J. are supported by the Alberta Heritage Foundation for Medical Research. F.A.M. is also supported by the Patient Health Management Chair at the University of Alberta. K.Z. is supported by research grants from the National Institute of Diabetes, Digestive and Kidney Disease of the National Institute of Health, an American Heart Association grant in aid and a philanthropic grant from Harold Simmons. G.F. is supported by the Ahmanson Foundation (Los Angeles, CA) and holds the Eliot Corday Chair in Cardiovascular Medicine and Science.
See page 872 for disclosure information.
PII: S1071-9164(10)00714-1
doi:10.1016/j.cardfail.2010.06.416
© 2010 Elsevier Inc. All rights reserved.
